A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Study on Asthma Characteristics

Recruiting
6 years or above
All
Phase N/A
2500 participants needed
4 Locations

Study Overview

The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life.

The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.

Eligibility Criteria

You may be eligible for this study if you meet the following criteria:

  • Conditions: Asthma
  • Age: 6 years or above
  • Gender: All

Inclusion Criteria:

Applicable for Part 1 participants:

  • Age 6 years and older, at the time of signing the informed consent
  • Physician diagnosis of asthma for at least 12 months
  • Existing treatment with low, medium, or high dose ICS and other asthma therapies as reflected in GINA 2-5 steps
  • Participant or legally authorized representative (where applicable) has consented to participate

Applicable for Part 2 participants:

  • Age 18 years and older, at the time of signing the informed consent.
  • Physician diagnosis of asthma for at least 12 months
  • Existing treatment with low or medium ICS and other asthma therapies as reflected in GINA 2-4 steps
  • Participant or legally authorized representative (where applicable) has consented to participate
  • Participants must meet the criteria for at least one of the cohorts below:

A) Asthma control cohorts

  1. ACQ-5 >= 1.5
  2. ACQ-5 < 1.5 (B) Type-2 biomarker cohorts
  3. Elevated T2 biomarkers (B1: Type-2-high cohort)
  4. Low T2 biomarkers (B2: Type-2-low cohort)

Participants are excluded from the study if any of the following criteria apply (applicable for both Part 1 and Part 2 participants):

  • Current diagnosis of chronic obstructive pulmonary disease (COPD) or congestive heart failure
  • Participants with moderate/severe cognitive impairment.
  • Participants with moderate/severe cardiac disease.
  • Participants on immunosuppressive medication for a chronic condition.
  • Participation in other interventional and noninterventional clinical study (currently or in the past 3 months)

The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

This study investigates asthma in people receiving routine clinical care. It aims to describe the characteristics of participants with asthma, including their sociodemographic and clinical traits, treatments, and how asthma affects their lives.

The study focuses on understanding the disease severity and health-related quality of life in asthma patients. It seeks to gather data on various aspects such as treatment burden and biomarkers.

  • Who can participate: Participants aged 6 years and older with a physician diagnosis of asthma for at least 12 months can join, provided they are on existing asthma treatments and do not have COPD, heart failure, or severe cognitive or cardiac issues.
  • Study details: Participants will provide data about their asthma, including symptoms and treatments, to understand changes in their condition over time.
Updated on 21 Apr 2026. Study ID: NCT07556159

Find a study site near you

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
United States Only: Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language